tm
Seeing Is Believing
tm
Seeing Is Believing
SKYE is currently covered by 2 analysts with an average price target of $13.23. This is a potential upside of $9.22 (229.93%) from yesterday's end of day stock price of $4.01.
Skye Bioscience, Common Stock's activity chart (see below) currently has 0 price targets and 8 ratings on display. The stock rating distribution of SKYE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 11 days.
Highest price target for SKYE is $14, Lowest price target is $14, average price target is $14.
Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 20-Sep-2024. First documented stock forecast 05-Feb-2024.
Currently out of the existing stock ratings of SKYE, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$14
$10.11 (259.90%)
$14
10 months 4 days ago
(20-Sep-2024)
0/6 (0%)
$10.86 (345.86%)
Buy
$12
10 months 4 days ago
(20-Sep-2024)
1/1 (100%)
$7.57 (170.88%)
22
What is SKYE (Skye Bioscience, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on SKYE (Skye Bioscience, Common Stock) with a proven track record?
Which analyst has the current lower performing score on SKYE (Skye Bioscience, Common Stock) with a proven track record?
Which analyst has the most public recommendations on SKYE (Skye Bioscience, Common Stock)?
Which analyst is the currently most bullish on SKYE (Skye Bioscience, Common Stock)?
Which analyst is the currently most reserved on SKYE (Skye Bioscience, Common Stock)?
